NCT04489160View on ClinicalTrials.gov

Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury

PHASE2UnknownINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2024

Conditions
Traumatic Brain InjuryTrauma, Head
Interventions
DRUG

C1 Inhibitor, Human

6000 IU C1-INH

DRUG

Placebo

0.9% saline

Trial Locations (3)

Unknown

RECRUITING

Leiden University Medical Center, Leiden

NOT_YET_RECRUITING

Erasmus Medical Center, Rotterdam

RECRUITING

Haaglanden Medisch Centrum, The Hague

Sponsors

Collaborators (1)

Takeda
All Listed Sponsors
collaborator

Netherlands Brain Foundation

OTHER

collaborator

Takeda

INDUSTRY

lead

Leiden University Medical Center

OTHER